BEIJING BOHUI INNOVATION BIOTECHNOLOGY GROUP CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.17 CNY | +8.16% |
|
+12.15% | -17.15% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Beijing Bohui Innovation Biotechnology Group Co Ltd, formerly Beijing Bohui Innovation Biotechnology Co Ltd, is a China-based company mainly engaged in inspection and testing business and blood products business. The Company operates two major reporting segments. The Inspection and Testing segment is mainly engaged in the research and development, production and sales of inspection instruments and inspection reagents. The Company's products for medical institutions mainly involve in vitro diagnostic testing, including human trace element testing and human papillomavirus (HPV) testing. The Company's testing equipment for non-medical institutions is mainly small mass spectrometers and related products. The Biological Products segment is mainly blood products, which can be divided into products such as albumin, immunoglobulin, coagulation factors and vaccines. The Company distributes its products within the domestic market and to overseas market.
Sector
Pharmaceuticals
Calendar
2024-05-17
- Annual General Meeting
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -17.15% | 583M | |
| -3.45% | 87.17B | |
| +1.97% | 40.1B | |
| +56.21% | 25.12B | |
| -14.82% | 15.59B | |
| -8.82% | 12B | |
| -16.29% | 11.8B | |
| -41.58% | 11.8B | |
| +6.14% | 8.81B | |
| -10.53% | 8.24B |
- Stock Market
- Equities
- 300318 Stock
- News Beijing Bohui Innovation Biotechnology Group Co., Ltd.
- Bohui Innovation Biotechnology Secures Blood Collection License in China’s Yunnan Province
